{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33974370", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "09"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.1097/j.jcrs.0000000000000672"], "Journal": {"ISSN": "1873-4502", "JournalIssue": {"Volume": "47", "Issue": "12", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "01"}}, "Title": "Journal of cataract and refractive surgery", "ISOAbbreviation": "J Cataract Refract Surg"}, "ArticleTitle": "Effectiveness of liposomal ozonized oil in reducing ocular microbial flora in patients undergoing cataract surgery.", "Pagination": {"StartPage": "1548", "EndPage": "1555", "MedlinePgn": "1548-1555"}, "Abstract": {"AbstractText": ["To evaluate the antimicrobial effectiveness of a liposomal ozonized oil solution used as a home therapy in patients undergoing cataract surgery. Antimicrobial efficacy was evaluated as the reduction in the bacterial load of the most common bacteria isolated from cases with endophthalmitis.", "20 Italian experimental centers of the Effectiveness of Liposomal Ozonized oil on Ocular Microbial flora before cataract surgery study group.", "Interventional, nonrandomized, paired-eye designed, phase 4 clinical study.", "A total of 174 patients undergoing cataract surgery were divided into 2 groups: the study group (174 eyes) underwent surgery and received an isotonic ophthalmic solution of 0.5% ozonized oil in liposomes plus hypromellose treatment (2 drops 4 times/d), and the control group (174 contralateral eyes) was treated with saline solution. The treatment lasted for 3 days. Subconjunctival swabs were taken from both eyes of each patient at T0 (the day before starting the treatment and 4 days preoperatively) and at T4 (after 3 days of treatment and 10 min preoperatively) and sent to the laboratory within 24 hours of collection for microbiological analysis.", "30% of 696 swabs taken at T0 were sterile. Contaminated swabs had a high prevalence of coagulase-negative staphylococci, including Staphylococcus epidermidis, and more than 60 different bacterial species were isolated. A significant reduction in microbial load was observed after treatment (>90% of the samples). The microbial load in the control group remained unchanged.", "Liposomal ozonized oil reduced the microbial burden after topical administration in a large study population."], "CopyrightInformation": "Copyright \u00a9 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "From the Eye Clinic, Policlinico Umberto I, \"Sapienza\" University of Rome, Rome, Italy (Spadea, Giannico); Microbiology and Virology Unit, University Hospital Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy (Zanotto, Cavallo); Department of Medical-Surgical Sciences and Translational Medicine, \"Sapienza\" University of Rome, Rome, Italy (Campagna); Department of Medicine and Health Science \"V. Tiberio,\" University of Molise, Campobasso, Italy (Costagliola)."}], "LastName": "Spadea", "ForeName": "Leopoldo", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zanotto", "ForeName": "Elisa", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cavallo", "ForeName": "Rossana", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Campagna", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Giannico", "ForeName": "Maria Ilaria", "Initials": "MI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Costagliola", "ForeName": "Ciro", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "CollectiveName": "ELOOM Study Investigators"}], "PublicationTypeList": ["Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Cataract Refract Surg", "NlmUniqueID": "8604171", "ISSNLinking": "0886-3350"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Cataract"}, {"QualifierName": [], "DescriptorName": "Cataract Extraction"}, {"QualifierName": [], "DescriptorName": "Conjunctiva"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Endophthalmitis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Liposomes"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr 2016;4:VMBF-0016-2015"}, {"Citation": "Halachmi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 2009;35:2109\u20132114"}, {"Citation": "Oakley CL, Vote BJ. Aqueous chlorhexidine (0.1%) is an effective alternative to povidone-iodine for intravitreal injection prophylaxis. Acta Ophthalmol 2016;94:e808\u2013e809"}, {"Citation": "Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol 2015;9:95\u2013108"}, {"Citation": "Reibaldi M, Avitabile T, Bandello F, Longo A, Bonfiglio V, Russo A, Castellino N, Rejdak R, Nowomiejska K, Toro M, Furino C, Cillino S, Fiore T, Cagini C, Grassi P, Musumeci R, Cocuzza CE, Martinelli M, Fallico M. The effectiveness of 0.6% povidone iodine eye drops in reducing the conjunctival bacterial load and needle contamination in patients undergoing anti-VEGF intravitreal injection: a prospective, randomized study. J Clin Med 2019;8:1031"}, {"Citation": "Travagli V, Zanardi I, Bocci V. Topical applications of ozone and ozonated oils as anti-infective agents: an insight into the patent claims. Recent Pat Antiinfect Drug Discov 2009;4:130\u2013142"}, {"Citation": "Valacchi G, Lim Y, Belmonte G, Miracco C, Zanardi I, Bocci V, Travagli V. Ozonated sesame oil enhances cutaneous wound healing in SKH1 mice. Wound Repair Regen 2011;19:107\u2013115"}, {"Citation": "Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol 2018;9:287\u2013298"}, {"Citation": "Pinna A, Molicotti P, Sechi LA, Lezcano I, Nunez N, Espim M, Dupre I. Antibacterial activity of ozonized sunflower oil (Oleozon). J Appl Microbiol 2001;90:279\u2013284"}, {"Citation": "Valacchi G, Fortino V, Bocci V. The dual action of ozone on the skin. Br J Dermatol 2005;153:1096\u20131100"}, {"Citation": "Kashiwagi K, Saito K, Wang YD, Takahashi H, Ishijima K, Tsukahara S. Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica 2001;215:351\u2013356"}, {"Citation": "Basile AA, Cendali M, Mandelli G, Fioretto G, Andrea C, Basile A, Science S, Andrea V. Anti-inflammatory effect of an eye drops solution based on liposomal ozonated oil in different corneal and anterior segment human diseases. Ozone Ther 2019;4:8377"}, {"Citation": "Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem 2015;61:100\u2013111"}, {"Citation": "Berkowitz J. Sample Size Estimation. Columbia University. Available at: http://www.columbia.edu/ . Accessed December 21, 2020"}, {"Citation": "Kahn H. Letter: Comparing the effects of 2 localized treatments on bilateral eye disease. Invest Ophthalmol Vis Sci 1974;13:634\u2013635"}, {"Citation": "Rosner B. Statistical methods in ophthalmology: an adjustment for the intraclass correlation between eyes. Biometrics 1982;38:105\u2013114"}, {"Citation": "Beaujean AA, Morgan GB. Tutorial on using regression models with count outcomes using R. Pract Assessment Res Eval 1996;21:2"}, {"Citation": "Nelder JA. Generalized linear models for enzyme-kinetic data. Biometrics 1991;47:1605\u20131610"}, {"Citation": "Moghimbeigi A, Eshraghian MR, Mohammad K, Mcardle B. Multilevel zero-inflated negative binomial regression modeling for over-dispersed count data with extra zeros. J Appl Stat 2008;35:1193\u20131202"}, {"Citation": "Wolfinger RD. Fitting Nonlinear Mixed Model with the New NLMIXED Procedure. Paper 287 in Statistics, Data Analysis and Modeling SUGI 24. SAS Institute Inc.; 1999"}, {"Citation": "Gliner JA, Morgan GA, Harmon RJ. Pretest-posttest comparison group designs: analysis and interpretation. J Am Acad Child Adolesc Psychiatry 2003;42:500\u2013503"}, {"Citation": "Dimitrov DM, Rumrill PD. Pretest-posttest designs and measurement of change. Work 2003;20:159\u2013165"}, {"Citation": "Agresti A. An Introduction to Categorical Data Analysis. 2nd ed. Hoboken, NJ: Wiley; 2006"}, {"Citation": "Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. John Wiley & Sons; 2000"}, {"Citation": "Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007;33:978\u2013988"}, {"Citation": "Stroman DW, Mintun K, Epstein AB, Brimer CM, Patel CR, Branch JD, Najafi-Tagol K. Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clin Ophthalmol 2017;11:707\u2013714"}, {"Citation": "Lu LJ, Liu J. Human microbiota and ophthalmic disease. Yale J Biol Med 2016;89:325\u2013330"}, {"Citation": "Koerner JC, George MJ, Meyer DR, Rosco MG, Habib MM. Povidone-iodine concentration and dosing in cataract surgery. Sure Ophthalmol 2018;63:862\u2013868"}, {"Citation": "Berkelman RL, Holland BW, Andreson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635\u2013639"}, {"Citation": "Kawana R, Kitamura T, Nakagomi O, Matsumoto I, Arita M, Yoshihara N, Yanagi K, Yamada A, Morita O, Yoshida Y, Furuya Y, Chiba S. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 1997;195:29\u201335"}, {"Citation": "Ta CN, Raizman MB, Gross RD, Joshi S, Mallick S, Wang Y, Segal B. A prospective, randomized trial of povidone-iodine 0.6% and dexamethasone 0.1% ophthalmic suspension for acute bacterial conjunctivitis. Am J Ophthalmol 2020;215:56\u201365"}, {"Citation": "Elvis A, Ekta J. Ozone therapy: a clinical review. J Nat Sci Biol Med 2011;2:66"}, {"Citation": "Naik SVRK, Kohli S, Zohabhsan S, Bhatia S. Ozone- a biological therapy in dentistry- reality or myth? Open Dent J 2016;10:196\u2013206"}, {"Citation": "Ross Fitzgerald J. The Staphylococcus intermedium group of bacterial pathogens: species re-classification, pathogenesis and the emergence of methicillin resistance. Vet Dermatol 2009;2:490\u2013495"}, {"Citation": "Song M, Zeng Q, Xiang Y, Gao L, Huang J, Huang Jin, Wu K, Lu J. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep 2018;17:2449\u20132455"}, {"Citation": "Celenza G, Iorio R, Cracchiolo S, Petricca S, Costagliola C, Cinque B, Segatore B, Amicosante G, Bellio P. Antimycotic activity of ozonized oil in liposome eye drops against Candida spp. TVST 2020;9:1\u201311"}, {"Citation": "Cutarelli A, Carlini G, Sarno F, Nebbioso A, Garofalo F, Altucci L, Corrado F. The role of ozone carried by liposomes in the therapy of infectious and skin-regenerating ocular surface. J Biomed Sci Engin 2019;12:347\u2013353"}, {"Citation": "Kim HS, Noh SU, Han YW, Kim KM, Kang H, Kim HO, Park YM. Therapeutic effects of topical application pf ozone on acute cutaneous wound healing. J Korean Med Sci 2009;24:368"}, {"Citation": "Silva V, Peirone C, Amaral JS, Capita R, Alonso-Calleja C, Marques-Magallanes JA, Martins \u00c2, Carvalho \u00c1, Maltez L, Pereira JE, Capelo JL, Igrejas G, Poeta P. High efficacy of ozonated oils on the removal of biofilms produced by methicillin-resistant Staphylococcus aureus (MRSA) from infected diabetic foot ulcers. Molecules 2020;25:3601"}, {"Citation": "Marchegiani A, Magagnini M, Cerquetella M, Troiano P, Franchini I, Franchini A, Scapagnini G, Spaterna A. Preoperative topical liposomal ozone dispersion to reduce barcterial colonization in conjunctival sac and periocular skin: preliminary study in dogs. Exp Eye Res 2019;189:107848"}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "10"}, {"Year": "2021", "Month": "4", "Day": "2"}, {"Year": "2021", "Month": "5", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "11", "Hour": "13", "Minute": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33974370", "10.1097/j.jcrs.0000000000000672", "02158034-202112000-00011"]}}], "PubmedBookArticle": []}